Status:
UNKNOWN
Povidone-iodine 2% Eye Drop Versus Artificial Tear Drop for Treatment of Adenoviral Keratoconjunctivitis
Lead Sponsor:
Farabi Eye Hospital
Conditions:
Adenoviral Keratoconjunctivitis
Eligibility:
All Genders
17+ years
Phase:
PHASE1
PHASE2
Brief Summary
Povidone-iodine 2% eye drop versus artificial tear drop for treatment of adenoviral keratoconjunctivitis
Detailed Description
Diagnosed EKC patients will be devided into two groups,first group will undergo povidone-iodine 2% eye drop four times a day and the control group will be treated only by artificial tear drops,they wi...
Eligibility Criteria
Inclusion
- Patients suspected for viral conjunctivitis
Exclusion
- Allergic to iodized materials
- Age under 17
Key Trial Info
Start Date :
August 23 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 22 2019
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04041856
Start Date
August 23 2019
End Date
November 22 2019
Last Update
August 1 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.